scispace - formally typeset
K

Kaylena A. Ehgoetz Martens

Researcher at University of Waterloo

Publications -  81
Citations -  2633

Kaylena A. Ehgoetz Martens is an academic researcher from University of Waterloo. The author has contributed to research in topics: Anxiety & Medicine. The author has an hindex of 19, co-authored 65 publications receiving 1633 citations. Previous affiliations of Kaylena A. Ehgoetz Martens include Wilfrid Laurier University & Woolcock Institute of Medical Research.

Papers
More filters
Journal ArticleDOI

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

TL;DR: In a prospective multicentre study involving 1280 patients with idiopathic RBD, Postuma et al. test the predictive power of 21 prodromal markers of neurodegeneration, providing a template for planning neuroprotective trials.
Journal ArticleDOI

Human cognition involves the dynamic integration of neural activity and neuromodulatory systems

TL;DR: It is found that neuronal activity converged onto a low-dimensional manifold that facilitates the execution of diverse task states and advance the understanding of functional brain organization by emphasizing the interface between neural activity, neuromodulatory systems, and cognitive function.
Journal ArticleDOI

Does anxiety cause freezing of gait in Parkinson's disease?

TL;DR: There is strong evidence that anxiety is an important mechanism underlying freezing of gait and the notion that the limbic system may have a profound contribution to freezing in PD is supported.
Journal ArticleDOI

The functional network signature of heterogeneity in freezing of gait.

TL;DR: The findings provide confirmatory evidence for systems-level impairments in the pathophysiology of freezing of gait and further advance the understanding of the whole-brain deficits that mediate symptom expression in Parkinson's disease.
Journal ArticleDOI

Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.

TL;DR: It is demonstrated that dopamine ameliorates gait automaticity in Parkinson's disease by altering striatal, limbic and cerebellar processing, thereby informing future therapeutic avenues for gait and falls prevention.